Archer E, Marlow ML, Lavie CJ Controversy and debate: Memory-Based Methods Paper 1: the fatal flaws of food frequency questionnaires and other memory-based dietary assessment methods. J Clin Epidemiol. 2018 Dec;104:113-124. doi: 10.1016/j.jclinepi.2018.08.003. Epub 2018 Aug 17.
Barnes RC, Krenek KA, Meibohm B, Mertens-Talcott SU, Talcott ST Urinary metabolites from mango (Mangifera indica L. cv. Keitt) galloyl derivatives and in vitro hydrolysis of gallotannins in physiological conditions. Mol Nutr Food Res. 2016 Mar;60(3):542-50. doi: 10.1002/mnfr.201500706. Epub 2016 Feb 2.
Cuparencu C, Rinnan A, Dragsted LO Combined Markers to Assess Meat Intake-Human Metabolomic Studies of Discovery and Validation. Mol Nutr Food Res. 2019 Sep;63(17):e1900106. doi: 10.1002/mnfr.201900106. Epub 2019 Jun 13.
Fulgoni VL 3rd, Dreher M, Davenport AJ Avocado consumption is associated with better diet quality and nutrient intake, and lower metabolic syndrome risk in US adults: results from the National Health and Nutrition Examination Survey (NHANES) 2001-2008. Nutr J. 2013 Jan 2;12:1. doi: 10.1186/1475-2891-12-1.
Giesbertz P, Brandl B, Lee YM, Hauner H, Daniel H, Skurk T Specificity, Dose Dependency, and Kinetics of Markers of Chicken and Beef Intake Using Targeted Quantitative LC-MS/MS: A Human Intervention Trial. Mol Nutr Food Res. 2020 Mar;64(5):e1900921. doi: 10.1002/mnfr.201900921. Epub 2020 Jan 29.
Nkobole N, Prinsloo G 1H-NMR and LC-MS Based Metabolomics Analysis of Wild and Cultivated Amaranthus spp. Molecules. 2021 Feb 4;26(4):795. doi: 10.3390/molecules26040795.
Vanderslice JT, Higgs DJ Vitamin C content of foods: sample variability. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1323S-1327S. doi: 10.1093/ajcn/54.6.1323s.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.